Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 4
2021 15
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Emerging role of exosomes in cancer progression and tumor microenvironment remodeling.
Paskeh MDA, Entezari M, Mirzaei S, Zabolian A, Saleki H, Naghdi MJ, Sabet S, Khoshbakht MA, Hashemi M, Hushmandi K, Sethi G, Zarrabi A, Kumar AP, Tan SC, Papadakis M, Alexiou A, Islam MA, Mostafavi E, Ashrafizadeh M. Paskeh MDA, et al. Among authors: saleki h. J Hematol Oncol. 2022 Jun 28;15(1):83. doi: 10.1186/s13045-022-01305-4. J Hematol Oncol. 2022. PMID: 35765040 Free PMC article. Review.
Quercetin in Attenuation of Ischemic/Reperfusion Injury: A Review.
Ashrafizadeh M, Samarghandian S, Hushmandi K, Zabolian A, Shahinozzaman M, Saleki H, Esmaeili H, Raei M, Entezari M, Zarrabi A, Najafi M. Ashrafizadeh M, et al. Among authors: saleki h. Curr Mol Pharmacol. 2021 Oct 25;14(4):537-558. doi: 10.2174/1874467213666201217122544. Curr Mol Pharmacol. 2021. PMID: 33334302 Review.
Interplay between SOX9 transcription factor and microRNAs in cancer.
Ashrafizadeh M, Zarrabi A, Orouei S, Zabolian A, Saleki H, Azami N, Bejandi AK, Mirzaei S, Janaghard MN, Hushmandi K, Nabavi N, Baradaran B, Kumar AP, Makvandi P, Samarghandian S, Khan H, Hamblin MR. Ashrafizadeh M, et al. Among authors: saleki h. Int J Biol Macromol. 2021 Jul 31;183:681-694. doi: 10.1016/j.ijbiomac.2021.04.185. Epub 2021 May 3. Int J Biol Macromol. 2021. PMID: 33957202 Review.
Resveratrol Augments Doxorubicin and Cisplatin Chemotherapy: A Novel Therapeutic Strategy.
Mirzaei S, Gholami MH, Zabolian A, Saleki H, Bagherian M, Torabi SM, Sharifzadeh SO, Hushmandi K, Fives KR, Khan H, Ashrafizadeh M, Zarrabi A, Bishayee A. Mirzaei S, et al. Among authors: saleki h. Curr Mol Pharmacol. 2023 Feb 23;16(3):280-306. doi: 10.2174/1874467215666220415131344. Curr Mol Pharmacol. 2023. PMID: 35430977 Review.
Targeted regulation of autophagy using nanoparticles: New insight into cancer therapy.
Paskeh MDA, Entezari M, Clark C, Zabolian A, Ranjbar E, Farahani MV, Saleki H, Sharifzadeh SO, Far FB, Ashrafizadeh M, Samarghandian S, Khan H, Ghavami S, Zarrabi A, Łos MJ. Paskeh MDA, et al. Among authors: saleki h. Biochim Biophys Acta Mol Basis Dis. 2022 Mar 1;1868(3):166326. doi: 10.1016/j.bbadis.2021.166326. Epub 2021 Dec 20. Biochim Biophys Acta Mol Basis Dis. 2022. PMID: 34942307 Free article. Review.
Novel Strategy in Breast Cancer Therapy: Revealing The Bright Side of Ginsenosides.
Hashemi F, Zarrabi A, Zabolian A, Saleki H, Farahani MV, Sharifzadeh SO, Ghahremaniyeh Z, Bejandi AK, Hushmandi K, Ashrafizadeh M, Khan H. Hashemi F, et al. Among authors: saleki h. Curr Mol Pharmacol. 2021;14(6):1093-1111. doi: 10.2174/1874467214666210120153348. Curr Mol Pharmacol. 2021. PMID: 33494691 Review.
EZH2 as a new therapeutic target in brain tumors: Molecular landscape, therapeutic targeting and future prospects.
Paskeh MDA, Mehrabi A, Gholami MH, Zabolian A, Ranjbar E, Saleki H, Ranjbar A, Hashemi M, Ertas YN, Hushmandi K, Mirzaei S, Ashrafizadeh M, Zarrabi A, Samarghandian S. Paskeh MDA, et al. Among authors: saleki h. Biomed Pharmacother. 2022 Feb;146:112532. doi: 10.1016/j.biopha.2021.112532. Epub 2021 Dec 11. Biomed Pharmacother. 2022. PMID: 34906772 Free article. Review.
21 results